Gilad Rabina

455 citations
48 papers · 270 indexed · h-index 10

Gilad Rabina

43 papers receiving 259 citations

Peers

Gilad Rabina
Comparison fields: 5 of 32
  • Ophthalmology 212
  • Radiology, Nuclear Medicine and Imaging 194
  • Neurology 37
  • Otorhinolaryngology 7
  • Public Health, Environmental and Occupational Health 44
Replace Sayyed Amirpooya Alemzadeh with:
Sayyed Amirpooya Alemzadeh Iran
Achia Nemet Israel
Victoria Kiavash Iran
Handan Canan Türkiye
Serhat İmamoğlu Türkiye
Rabia Sakarya Türkiye
Zi̇ya Ayhan Türkiye
Emine Akçay Türkiye
Maeve O’Doherty Ireland
Fatih Horozoğlu Türkiye
Gilad Rabina relative to Sayyed Amirpooya Alemzadeh Iran Sayyed Amirpooya Alemzadeh's profile →
Citations per field
00.5×1.5×
Sayyed Amirpooya Alemzadeh · 1×
Citations per year

Countries citing papers authored by Gilad Rabina

Since Specialization
Citations

This map shows the geographic impact of Gilad Rabina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilad Rabina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilad Rabina more than expected).

Fields of papers citing papers by Gilad Rabina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilad Rabina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilad Rabina. The network helps show where Gilad Rabina may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gilad Rabina, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gilad Rabina Line = papers co-authored together Gilad Rabina links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20235
3 20231
4 20222
5 20220
6 20223
7 20210
8 20202
9 20202
10 202013
11 20207
12 20201
13 20201
14 20209
15 201930
16 20195
17 20192
18 20186
19 20184
20 201316

About Gilad Rabina

Gilad Rabina is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Public Health, Environmental and Occupational Health, having authored 48 papers that have together received 270 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (21 papers), Glaucoma and retinal disorders (19 papers), Corneal surgery and disorders (17 papers), Retinal and Macular Surgery (11 papers), Retinal and Optic Conditions (9 papers), Ocular Surface and Contact Lens (9 papers), Ophthalmology and Visual Impairment Studies (8 papers) and Intraocular Surgery and Lenses (7 papers). The work is most often cited by research in Ophthalmology (212 citations), Radiology, Nuclear Medicine and Imaging (194 citations) and Neurology (37 citations). Gilad Rabina has collaborated with scholars based in Israel, United States and France. Frequent co-authors include Michael Mimouni, Igor Kaiserman, Shulamit Schwartz, Adiel Barak, Anat Loewenstein, Igal Leibovitch, Shani Golan, Anat Loewenstein, Omer Trivizki and Elad Moisseiev. Their work appears in journals such as American Journal of Ophthalmology, Journal of Cataract & Refractive Surgery and Retina.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026